8 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
in Pulmonary Arterial ... Hypertension (PAH ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
(PAH) Management ... Algorithm Dr. ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
High Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH #Management #Algorithm
High Risk Pulmonary ... (PAH) Management ... Algorithm Dr. ... #PAH #Management ... #Algorithm #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... pharmacotherapy #decisionaid ... #cardiology #hematology
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... risk of serious bacterial ... Procalcitonin <0.5 ng/mL ... #Diagnosis #Management ... #Pediatrics #Peds
Portopulmonary Hypertension
Presence of pulmonary arterial hypertension in a patient with portal hypertension
No other obvious causes (chronic
arterial hypertension ... 3 Woods units, PA ... pressure < 15mmHg TREATMENT ... Hypertension #diagnosis #management ... #hepatology
The crusade against “Ab”Normal Saline continues.  This is a non-physiologic fluid that can harm our
against the drop in pH ... of the afferent arteriole ... #criticalcare #management ... #diagnosis #treatment ... #pharmacology #
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
amyloidosis, PAH ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... #Diagnosis #Management